muscle
|
|
• ejection fraction and fractional shortening are increased by 22% and 36% respectively
|
|
|
• myofibers in gastrocnemius and triceps are more heterogenous and smaller in size
• on average, there is a 28% and 32% decrease in myofiber size in the gastrocnemius and triceps, respectively, at 54 weeks of age, but not in the diaphragm
• however, no difference in the average minimum Ferets diameter is seen in skeletal muscle
|
|
|
• in gastrocnemius, triceps, and diaphragm from 12-week-old mice, 60%, 69%, and 52% of myofibers contain centralized nuclei, respectively
• in gastrocnemius, triceps, and diaphragm from 52-week-old mice, 57%, 60%, and 45% of myofibers contain centralized nuclei, respectively
|
|
|
• increase in muscle turnover in the gastrocnemius and triceps but not in the diaphragm is seen at 12 weeks of age and at 52 weeks of age indicative of excessive muscle degeneration
|
|
|
• increase in fibrosis in gastrocnemius, triceps, diaphragm, and heart tissue by 2.9-, 3.6-, 2.4-, and 3.8-fold, respectively
• 2-fold increase in fibrosis in the diaphragm at 52 weeks compared to 12 weeks of age
|
|
|
• mice develop progressive muscular dystrophy
|
cardiovascular system
|
|
• cardiomyocytes show increased cell surface area of approximately 1.4-fold at both 12 and 52 weeks of age, indicating cardiac hypertrophy
• muscle histology shows that pseudohypertrophy is primarily attributed to fibrotic development
|
|
|
• ejection fraction and fractional shortening are increased by 22% and 36% respectively
|
|
|
• echocardiography shows that during systole and diastole, a 15-25% and 8-21% increase in posterior wall thickness occurs, respectively, a reduction in chamber systolic volume by 41% and diastolic volume by 22%, and reduced ventricular diameter by 19% during systole and 9% during diastole, indicating a constrictive hypertrophic response
|
|
|
• heart rate is increased by 22%, 17%, and 27% at 12-, 28-, and 52-weeks of age, indicating consistent tachycardia
|
behavior/neurological
|
|
• mice show weakened muscle strength from 12 to 52 weeks of age, where there is decreased grip strength by 20-30%
|
growth/size/body
|
|
• cardiomyocytes show increased cell surface area of approximately 1.4-fold at both 12 and 52 weeks of age, indicating cardiac hypertrophy
• muscle histology shows that pseudohypertrophy is primarily attributed to fibrotic development
|
|
|
• heavier body weight at 12 and 52 weeks of age
|
homeostasis/metabolism
|
|
• serum creatine kinase level is elevated approximately 1.7-fold at both 12 and 52 weeks of age
|
|
|
• mice exhibit higher number of damaged fibers after the treadmill regimen indicating increased exercise-induced muscle damage
• mice show no increase in tetanic force after exercise as is seen in wild-type mice
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
| Duchenne muscular dystrophy | DOID:11723 |
OMIM:310200 |
J:296560 | |


Analysis Tools